Phase I – Other

1,082 trials 243 recruiting

Filter these 1,082 trials by condition, country, sponsor and more.

Open in Search →

A trial to learn how much budesonide, glycopyrronium, and formoterol fumarate (BGF) gets into and moves throughout the body when it is taken… Ended

2023-504089-43-00 Not applicable, healthy volunteers 2024-03-14
Study to Assess the Effect of Food on the Pharmacokinetics of CA-4948 in Healthy Male Subjects Ended

2023-509691-41-00 Hematologic malignancies 2024-03-14
A PHASE I, OPEN-LABEL, RANDOMIZED, ADAPTIVE, CROSS-OVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF NIZUBAGLUSTAT CAPSULES COMPARED T… Ended

2023-510058-17-00 Glycosphingolipid lysosomal storage disorders 2024-03-12
A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR) Ended

2023-507721-41-00 polymyalgia rheumatica 2024-03-11
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-1117570 in Healthy Adults Ended

2023-508814-40-00 Neurological and neuropsychiatric conditions 2024-03-11
A Phase 1b, Open-Label, Multiple Ascending Dose, Multicenter Study of VRG50635 in Participants With Sporadic and Familial Amyotrophic Latera… Ended

2023-506509-21-00 Amyotrophic Lateral Sclerosis 2024-03-08
A six-way relative bioavailability study comparing 10, 30, 40 and 50 mg leniolisib film coated tablets and 30 mg film coated granules with 7… Ended

2023-508880-61-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 2024-03-06
Physiologically based pharmacokinetic modelling of intravenous and intranasal formulations of naloxone in healthy volunteers Ended

2023-506064-14-00 Healthy volunteers 2024-03-05
Double-Blind, Randomized, Placebo-Controlled, Phase 1b, Pharmacodynamic Trial of TEV-56192 Following a Single Intravenous Administration in … Ended

2023-507018-29-00 Pruritus 2024-03-05
A study to test whether multiple doses of BI 456906 have an effect on cardiac safety in people with overweight or obesity. Ended

2023-506375-10-00 Healthy volunteer trial 2024-03-04
A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma Ended

2023-504304-29-00 Moderate to Severe Asthma 2024-03-01
A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus Ended

2023-506499-29-00 Systemic Lupus Erythematosus 2024-02-28
A trial to determine how nanatinostat is absorbed, modified, and removed from the body and the amount of nanatinostat that becomes available… Ended

2023-508184-74-00 Advanced cancer 2024-02-28
Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in com… Ended

2023-507241-28-00 Test of vasocontriction properties for classification o 2024-02-26
Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303) Ended

2022-502940-10-00 Advanced Solid Tumors 2024-02-23
This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adu… Ended

2023-504800-28-00 Chronic Inducible Urticaria 2024-02-23
A study to Assess the Effect of Fluvoxamine (CYP2C19 Inhibitor), Itraconazole (CYP3A4 Inhibitor) and Paroxetine (CYP2D6 Inhibitor) on the Ph… Ended

2023-508382-33-01 Proteinopathies 2024-02-22
A study to test how a new long-acting insulin works in the body of patients with type 2 diabetes during exercise and prolonged fasting. Ended

2023-505012-38-00 Type 2 diabetes 2024-02-21
A research study to look at how CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight Ended

2023-504792-24-00 Obesity 2024-02-20
A study to learn how different forms of study medicine tafamidis are taken up into the blood in healthy adults Ended

2023-509241-12-00 aransthyretin amyloid cardiomyopathy 2024-02-15
Study to measure filgotinib in the blood of children and teenagers with arthritis taking filgotinib-GLPG0634-CL-131 Ended

2023-505844-21-00 juvenile idiopathic arthritis 2024-02-14
A SINGLE-CENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF REPEAT DOSES OF ARM210 IN HEAL… Ended

2023-509086-20-00 Cardiac arrhythmias 2024-02-13
A study of how CagriSema works on appetite in people with excess body weight Ended

2023-504782-23-00 Obesity 2024-02-09
MK-7480 Multiple Ascending Dose Study in Healthy Participants Ended

2023-508982-34-00 Non-alcoholic steatohepatitis 2024-02-09